-
Costs of Type 2 Diabetes Mellitus and Obesity in Colombian Caribbean Poor Population: A Top-Down Approach from a Cardiovascular Risk Cohort, 2020-2022
Mar 10, 2025, 14:00 PM -
Medication Utilization Post Selective Laser Trabeculoplasty or Minimally Invasive Glaucoma Surgeries in Patients With Open-Angle Glaucoma or Ocular Hypertension: A Systematic Review of Recent Literature
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Technological Innovation for Chronic Wounds: Pharmacoeconomic Model Based on LOGIT and MAIC Tools
Mar 10, 2025, 14:00 PM -
Characterizing Cardiovascular Disease Patients in US Community Hospitals Using InsightsDB
Mar 10, 2025, 14:00 PM -
The Costs Associated with Healthcare Resource Use and Work Productivity for Care Partners of Multiple Myeloma Patients in the United States and Europe
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Next-Generation Sequencing Technologies in Paediatric Patient Groups With Rare Diseases: a Systematic Review
Mar 10, 2025, 14:00 PM -
Identifying Treatment Patterns for Essential Thrombocythemia Using Real-world Data
Mar 10, 2025, 14:00 PM -
Impact of Cardiovascular, Renal and Metabolic Comorbidities on Activity and Health-Related Quality of Life in Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada
Mar 10, 2025, 14:00 PM -
Costs of Care for Patients With Triple Negative Metastatic Breast Cancer: A Retrospective US Claims Data Study
Mar 10, 2025, 14:00 PM -
Analysis of Reimbursement Outcomes for Oncology Therapies in Quebec, Canada
Mar 10, 2025, 14:00 PM -
Advancing Real World Evidence: Comparative Insights into Global Practices and China's Strategic Progress
Mar 10, 2025, 14:00 PM -
Treatment Experience and Other Health and Social Characteristics Among Patients With Cancer From a Large US Population-Based Survey
Mar 10, 2025, 14:00 PM -
The Inflation Reduction Act: Evaluating Impact on Medicare Drug Pricing, Innovation, and Access to Therapies
Mar 10, 2025, 14:00 PM -
Treatment Preferences Related to Long-Acting Injectable Buprenorphine Among Patients With Opioid Use Disorder in Australia, Finland, Germany, and Italy
Mar 10, 2025, 14:00 PM -
Real-World Persistence to Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis in a Commercial and Medicare Advantage Population
Mar 10, 2025, 14:00 PM -
Why It Is Still Important to Ensure the Price is Right: Updates to Access Restrictions for Therapies Treating Duchenne Muscular Dystrophy
Mar 10, 2025, 14:00 PM -
Can We Move Beyond a Best Guess? The Feasibility of Transportability Analysis to Estimate the Effect of GLP-1 Inhibitors in the Canadian Population
Mar 10, 2025, 14:00 PM -
A Qualitative Assessment of Emergency Physician Perceptions and Experiences with Acute Pain Management
Mar 10, 2025, 14:00 PM -
Economic and Healthcare Burden in Patients With Fragile X Syndrome: A Systematic Review
Mar 10, 2025, 14:00 PM -
The Relationship Between Weight and Disease Severity in Dogs with Chronic Kidney Disease: Results from a Real-World Study
Mar 10, 2025, 14:00 PM
